Search Knowledge Base

9 results for "deferoxamine"

A systematic review and meta-analysis of deferiprone monotherapy and in combination with deferoxamine for reduction of iron overload in chronically transfused patients with β-thalassemia pubmed_article
Evidence Source 2014 PMID: 25307964
Iron chelators for acute stroke pubmed_article
Evidence Source 2020 PMID: 33236783
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia pubmed_article
Evidence Source 2013 PMID: 23963793
Oral deferiprone for iron chelation in people with thalassaemia pubmed_article
Evidence Source 2013 PMID: 23966105
Deferasirox for managing iron overload in people with thalassaemia pubmed_article
Evidence Source 2012 PMID: 22336831
Deferasirox for managing transfusional iron overload in people with sickle cell disease pubmed_article
Evidence Source 2010 PMID: 20687088
Oral deferiprone for iron chelation in people with thalassaemia pubmed_article
Evidence Source 2007 PMID: 17636775
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia pubmed_article
Evidence Source 2005 PMID: 16235363
Efficacy and safety of iron chelators in thalassemia and sickle cell disease: a multiple treatment comparison network meta-analysis and trial sequential analysis pubmed_article
Evidence Source PMID: 29727586

Evidence Search Results semantic · quality-ranked

A systematic review and meta-analysis of deferiprone monotherapy and in combination with deferoxamine for reduction of iron overload in chronically transfused patients with β-thalassemia meta_analysis pubmed_article
Quality: 60 2014 PMID: 25307964 DOI: 10.3109/03630269.2014.965781
Efficacy of the iron-chelating agent, deferiprone, in patients with Parkinson's disease: A systematic review and meta-analysis meta_analysis pubmed_article
Quality: 73 2024 PMID: 38334258 DOI: 10.1111/cns.14607
No difference in myocardial iron concentration and serum ferritin with deferasirox and deferiprone in pediatric patients with hemoglobinopathies: A systematic review and meta-analysis meta_analysis pubmed_article
Quality: 51 2023 PMID: 35878782 DOI: 10.1016/j.tracli.2022.07.004
Provision of folic acid for reducing arsenic toxicity in arsenic-exposed children and adults systematic_review pubmed_article
Quality: 68 2021 PMID: 34661903 DOI: 10.1002/14651858.CD012649.pub2
Deferasirox for managing iron overload in people with thalassaemia meta_analysis pubmed_article
Quality: 67 2017 PMID: 28809446 DOI: 10.1002/14651858.CD007476.pub3
p-Synephrine, the main protoalkaloid of Citrus aurantium, raises fat oxidation during exercise in elite cyclists rct pubmed_article
Quality: 58 2021 PMID: 32859142 DOI: 10.1080/17461391.2020.1817154
Oral deferiprone for iron chelation in people with thalassaemia meta_analysis pubmed_article
Quality: 71 2013 PMID: 23966105 DOI: 10.1002/14651858.CD004839.pub3
Oral deferiprone for iron chelation in people with thalassaemia meta_analysis pubmed_article
Quality: 65 2007 PMID: 17636775
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia meta_analysis pubmed_article
Quality: 71 2013 PMID: 23963793 DOI: 10.1002/14651858.CD004450.pub3
Deferasirox for managing iron overload in people with thalassaemia meta_analysis pubmed_article
Quality: 66 2012 PMID: 22336831 DOI: 10.1002/14651858.CD007476.pub2

View full evidence search →